User profiles for Pierluigi Navarra

Pierluigi Navarra

Catholic University Medical School
Verified email at unicatt.it
Cited by 9421

n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE 2 induced ERK-1 and -2 and HIF-1α induction pathway

…, S Serini, N Maggiano, G Tringali, P Navarra… - …, 2004 - academic.oup.com
n-3 Polyunsaturated fatty acids (PUFAs) inhibit the development of microvessels in mammary
tumors growing in mice. Human colorectal tumors produce vascular endothelial growth …

The role of small intestinal bacterial overgrowth in Parkinson's disease

…, G Gigante, EC Lauritano, P Navarra… - Movement …, 2013 - Wiley Online Library
Parkinson's disease is associated with gastrointestinal motility abnormalities favoring the
occurrence of local infections. The aim of this study was to investigate whether small intestinal …

Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study

…, RL Stephen, G Capelli, P Navarra… - The Journal of …, 2003 - auajournals.org
Purpose : In laboratory studies electromotive mitomycin C (MMC) demonstrated markedly
increased transport rates compared with passive transport. We performed a prospective study …

Interleukins-1 and -6 Stimulate the Release of Corticotropin-Releasing Hormone-41 from Rat Hypothalamus in Vitro via the Eicosanoid Cyclooxygenase Pathway

P NAVARRA, S TSAGARAKIS, MS FARIA… - …, 1991 - academic.oup.com
It has previously been shown that interleukin-1 (IL-1) directly stimulates the release of CRH-41
from rat hypothalamus in vitro, suggesting that cytokines may mediate the effects of …

Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology

…, A De Corato, L Lisi, G Tringali, P Navarra… - Molecular …, 2009 - journals.sagepub.com
Background Migraine is a complex, chronic, painful, neurovascular disorder characterized
by episodic activation of the trigeminal system. Increased levels of calcitonin gene-related …

Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma

…, A Coli, A Mangiola, C Anile, DL Feinstein, P Navarra - Neuroscience …, 2017 - Elsevier
Microglia and macrophages appear to be the most common cells in the GBM microenvironment.
In the present study we investigated the status of macrophages/microglia activation in …

[HTML][HTML] The human microglial HMC3 cell line: where do we stand? A systematic literature review

…, D Mezzogori, F Paciello, G Pozzoli, P Navarra… - Journal of …, 2018 - Springer
Microglia, unique myeloid cells residing in the brain parenchyma, represent the first line of
immune defense within the central nervous system. In addition to their immune functions, …

Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation

CD Russo, L Lisi, G Tringali, P Navarra - Biochemical pharmacology, 2009 - Elsevier
Neuroinflammation plays a prominent role in the pathophysiology of several neurodegenerative
disorders, including Multiple Sclerosis. Reactive microglial cells are always found in …

[HTML][HTML] Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches

F Ricci, F Bandello, P Navarra, G Staurenghi… - International journal of …, 2020 - mdpi.com
Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive
retinal degenerative disease of the macula that affects elderly people and cause central …

Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer

G Graziani, L Tentori, P Navarra - Pharmacological research, 2012 - Elsevier
Ipilimumab (Yervoy, developed by Medarex and Bristol-Myers Squibb) is a fully human
monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), an immune-…